Chen Yu, Dai Yuxuan, Wang Xing, Liu Jian
Department of Surgical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, No. 79 Qingchun Road, Hangzhou, 310016, Zhejiang, China.
Department of Plastic Surgery, Beilun Branch of the First Affiliated Hospital, College of Medicine, Zhejiang University, Ningbo, Zhejiang, China.
Discov Oncol. 2025 Jul 1;16(1):1221. doi: 10.1007/s12672-025-03059-0.
OBJECTIVE: This study aims to qualitatively and quantitatively assess the research landscape of palmitoylation in oncology using bibliometric analysis, thereby providing insights into research hotspots and emerging trends. METHODS: The data were sourced from the Web of Science Core Collection, retrieved using predefined search terms, and comprise review articles and original research papers published in English from 2004 to 2024. Bibliometric analysis and data visualization were performed using VOSviewer, CiteSpace, and Microsoft Excel. RESULTS: The United States and China are the leading contributors to research in this field, with Shanghai Jiao Tong University being the most prolific institution in terms of publication output. Current research hotspots in protein palmitoylation related to oncology primarily encompass the enzymatic mechanisms and dynamic regulation of palmitoylation, palmitoylation-mediated lipid metabolic reprogramming and tumorigenesis, palmitoylation-mediated tumor signaling pathways, and targeted cancer therapy strategies based on palmitoylation modification. Current research trends primarily focus on the modulation of critical enzymes and signaling pathways, which influence tumor biology and prognosis. Additionally, emphasis is placed on metabolic reprogramming mediated by protein palmitoylation within the tumor microenvironment, especially regarding its role in tumor responsiveness to chemotherapy and immunotherapy. CONCLUSION: This study provides a comprehensive overview of recent advancements in research regarding protein palmitoylation modifications within oncology.
目的:本研究旨在通过文献计量分析对肿瘤学中棕榈酰化的研究格局进行定性和定量评估,从而深入了解研究热点和新趋势。 方法:数据来源于科学网核心合集,使用预定义的检索词进行检索,包括2004年至2024年以英文发表的综述文章和原创研究论文。使用VOSviewer、CiteSpace和Microsoft Excel进行文献计量分析和数据可视化。 结果:美国和中国是该领域研究的主要贡献者,上海交通大学是发表量最多的机构。目前与肿瘤学相关的蛋白质棕榈酰化研究热点主要包括棕榈酰化的酶促机制和动态调控、棕榈酰化介导的脂质代谢重编程与肿瘤发生、棕榈酰化介导的肿瘤信号通路以及基于棕榈酰化修饰的靶向癌症治疗策略。当前的研究趋势主要集中在对影响肿瘤生物学和预后的关键酶和信号通路的调控上。此外,重点关注肿瘤微环境中蛋白质棕榈酰化介导的代谢重编程,特别是其在肿瘤对化疗和免疫治疗反应中的作用。 结论:本研究全面概述了肿瘤学中蛋白质棕榈酰化修饰研究的最新进展。
Nat Commun. 2025-1-20
Sci Immunol. 2024-11-15
Int J Surg. 2024-7-1
Nat Rev Mol Cell Biol. 2024-6